| Home | Clinical Care | Research | Training | Division Activities |
|
|
|
|
||
UW Clinical Hematology and Transfusion Medicine Research Career Development Program (K12) Program Description This is an award for career development in benign hematology research. Benign hematology (as defined by the NIH) includes studies in hemostasis and classical benign hematology, as well as MDS and myeloproliferative disorders, but not CLL or leukemia. Studies of cardiovascular and cerebrovascular thromboembolic diseases are specifically excluded from funding. The grant provides resources (some linked to the UW Institute of Translational Health Sciences (ITHS)), so that our scholars can train in the way most optimal for their career development. This grant is for CLINICAL RESEARCH defined broadly to include clinical trials and studies, cost-efficacy and outcome studies, as well as studies of disease pathogenesis using human samples. Applicants must have a faculty position (e.g., acting instructor) at the time that their funding initiates. The typical scholar will have just completed his/her fellowship training in adult or pediatric hematology, transfusion medicine, or a related field. K12 support is generally for 2 years. PhDs are technically eligible provided their career goals are benign hematology clinical research. We can also support more senior individuals such as an assistant professor who would like 2 years of protected time to develop or refine credentials in clinical research (or, for example, obtain an MPH degree). We intend to use this grant creatively to maximally benefit our applicants. We will thus judge our success by whether our scholars obtain K23 awards, K08 awards or other grant funding; whether they present their research findings at national meetings (such as ASH); whether they publish their results in prominent journals; and most importantly, whether they obtain “tenure track” or equivalent academic positions at UW or elsewhere. Please note that although K23 and K08 support is limited to 5 years, the NIH allows a 6-year total for K support. Thus, we envision that after 1 or 2 years of K12 funding, the typical scholar would begin K23 or K08 funding for 5 or 4 years, respectively. If a scholar obtains a K23 or K08 award after 1 year of K12 funding, we will use the K12 slot for another trainee. Funding for each scholar is similar to other K awards and includes $75,000/y for salary support and the requirement that he/she spend at minimum 75% effort on grant activities. Up to $30,000 is provided each year for supplies/technician or research nurse assistance/statistical services/travel/tuition, etc. Notably, we can also provide 2% FTE (subject to the NIH salary rules) of salary and benefits support to the primary mentor. The scholar and mentor must attend the annual K12 trainees meeting. Dr. Janis Abkowitz (PI), Dr. José López and Dr. Barbara Konkle (Co-PI’s) are happy to speak directly to potential applicants or mentors. Dr. Abkowitz can be reached by telephone at 206-685-7877 or by e-mail at janabk@uw.edu, Dr. López can be reached through his assistant at 206-568-2244 or by e-mail at josel@psbc.org, and Dr. Konkle can be reached through her assistant at 206-398-5948, or by e-mail at BarbaraK@psbc.org. Eligibility To be eligible for this program, you must:
You are ineligible if you:
Timing of Application Process Your application must be received by November 26, 2012. An important component of this application will be your personal interview with K12 faculty members. Interviews will be conducted in December. The selection committee intends to notify applicants of funding decisions by December 17, 2012. The K12 fellowship will begin between January 1, 2013 and July 1, 2013, and funds will be available for 2 years. Application Instructions Here is the Application Form. Please send all materials electronically to Dr. Janis Abkowitz c/o Zeny Sisk (zsisk@uw.edu), K12 in Benign Clinical Hematology Research Program. Zeny Sisk |